论文信息 - Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial - 字舞流文

Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial

L. Kappos | H. Hartung | M. Freedman | E. Radü | M. Lamarine | D. Mikol | A. Boyko | T. Plitz | Yann Hyvert | U. Freudensprung | J. Beek | Y. Hyvert